NZ705637A - Improved methods and compositions for wound healing - Google Patents

Improved methods and compositions for wound healing

Info

Publication number
NZ705637A
NZ705637A NZ705637A NZ70563707A NZ705637A NZ 705637 A NZ705637 A NZ 705637A NZ 705637 A NZ705637 A NZ 705637A NZ 70563707 A NZ70563707 A NZ 70563707A NZ 705637 A NZ705637 A NZ 705637A
Authority
NZ
New Zealand
Prior art keywords
compositions
wound healing
connexin
improved methods
medicament
Prior art date
Application number
NZ705637A
Inventor
Colin R Green
David L Becker
Bradford J Duft
Original Assignee
Coda Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coda Therapeutics Inc filed Critical Coda Therapeutics Inc
Publication of NZ705637A publication Critical patent/NZ705637A/en

Links

Abstract

Disclosed is a use of (a) a connexin agent and (b) an antagonist of VEGF effective in promoting or improving healing, in the manufacture of a medicament for promoting or improving healing of optic nerve or eye tissue in a subject in need thereof; wherein the connexin agent is an anti-connexin 43 polynucleotide or a connexin peptide or peptidomimetic; and wherein the medicament is formulated for separate, sequential or simultaneous administration of (a) and (b).
NZ705637A 2006-11-15 2007-11-15 Improved methods and compositions for wound healing NZ705637A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85943706P 2006-11-15 2006-11-15
NZ61472407 2007-11-15

Publications (1)

Publication Number Publication Date
NZ705637A true NZ705637A (en) 2016-11-25

Family

ID=57395710

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ705637A NZ705637A (en) 2006-11-15 2007-11-15 Improved methods and compositions for wound healing

Country Status (1)

Country Link
NZ (1) NZ705637A (en)

Similar Documents

Publication Publication Date Title
MX2009005644A (en) Gel useful for the delivery of ophthalmic drugs.
UA101309C2 (en) Activin-actrii antagonists thereof and uses for increasing red blood cell levels
WO2012071559A3 (en) Therapeutic methods and compositions for solid delivery
TW200616608A (en) Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
PL385586A1 (en) New slow-release insulin analogues
WO2005107726A3 (en) Method for the treatment of back pain
WO2005105107A3 (en) Hormone treatment of multiple sclerosis
WO2007058990A3 (en) Therapy using cytokine inhibitors
RS54707B1 (en) Treatment of crohn's disease with laquinimod
WO2006113802A3 (en) Device for administering electrode stimulation of back and abdominal muscles
WO2007035473A3 (en) Pharmaceutical delivery device and method for providing ocular treatment
WO2009045309A3 (en) Use of v2 receptor antagonists in combination with vasopressinergic agonists
ATE456369T1 (en) FLIBANSERIN FOR THE TREATMENT OF URINARY INCONTINENCE AND ASSOCIATED DISEASES
MX2012000275A (en) Acid pump antagonist for treatment of diseases associated with abnormal gastrointestinal movement.
MX2009011900A (en) Diabetic wound healing.
WO2011028794A3 (en) Treatment of huntington's disease with cycloserine and an nmda receptor antagonist
WO2007105203A3 (en) Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
ATE539676T1 (en) DEVICE FOR ADMINISTRATION OF AN IMPLANTABLE MONITOR
HK1112721A1 (en) Tissue disruption treatment and composition for use thereof
CY1110182T1 (en) IDEENONON FOR THE TREATMENT OF MUSCLE DYSTROPHY
MX2009004051A (en) Use of il-1 antagonists to treat gout and pseudogout.
MX2007010295A (en) Ophthalmologic compositions and use mode thereof.
WO2004039325A3 (en) Treatment of pain with jnk inhibitors
SG160323A1 (en) Methods for controlling angiogenesis and cell proliferation
CA2899775C (en) Compositions and methods for pain relief without numbness

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 6 YEARS UNTIL 15 NOV 2017 BY AJ PARK

Effective date: 20170627

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 NOV 2018 BY CPA GLOBAL

Effective date: 20170929

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 NOV 2019 BY CPA GLOBAL

Effective date: 20181004

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 NOV 2020 BY CPA GLOBAL

Effective date: 20191003

LAPS Patent lapsed